Clinical Trial Update: Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome [Phase 4]

View source ↗

Summary

Osilodrostat is being studied in a Phase 4 trial for hypertension caused by hypercortisolemia due to Cushing's syndrome. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome
• Hypertension

Drugs mentioned

• Isturisa (osilodrostat)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Hypertension, Hypercortisolemia | Phase 4 | Status: NOT_YET_RECRUITING